Sabeluzole (R-58735) is a nootropic and neuroprotective drug which was originally developed for the treatment of Alzheimer’s disease and has subsequently been researched for other applications such as sleep apnoea. It acts primarily as an NMDA antagonist but other mechanisms of action may also be important.
This page contains content from the copyrighted Wikipedia article "Sabeluzole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
